ECHO: Study design and baseline characteristics of a non-interventional cohort study of esketamine nasal spray in treatment resistant depression / Eric Constant, Christine Reif-Leonhard, Ángela Ibañez, Lars Häggström, Yordan Godinov, Benoît Rive, Christian von Holt, Yerkebulan Kambarov, Gianluca Rosso ; ECNP Congress (38. : 2025 : Amsterdam)

Related documents

• Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study / Andreas Reif, A. Elif Anıl Yağcıoğlu, István Bitter, Jozefien Buyze, Richard Frey, Dong-Jing Fu, Yordan Godinov, Lars Häggström, Yerkebulan Kambarov, René Ernst Nielsen, Albino Jorge Oliveira-Maia, Christian von Holt, Allan H. Young, Wiesław J. Cubała#1078728
• Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report#481883
• Erratum to "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: results from the ESCAPE-LTE study" [European Neuropsychopharmacology 107 (2026) 112801] / Andreas Reif, A. Elif Anıl Yağcıoğlu, István Bitter, Jozefien Buyze, Richard Frey, Dong-Jing Fu, Yordan Godinov, Lars Häggström, Yerkebulan Kambarov, René Ernst Nielsen, Albino Jorge Oliveira-Maia, Christian von Holt, Allan H. Young, Wiesław J. Cubała#1078719
• A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression#874283
• Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects#257428